Penserra Capital Management’s Outset Medical OM Stock Holding History

Penserra Capital Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-528	Closed	-$42K	–	1375
2023 Q4	$42K	Buy	528 +306	+138%	+$24.9K	﹤0.01%	1030
2023 Q3	$36K	Sell	222 -61	-22%	-$14.4K	﹤0.01%	1034
2023 Q2	$92K	Buy	283 +245	+645%	+$74.7K	﹤0.01%	957
2023 Q1	$10K	Buy	38 +10	+36%	+$3.67K	﹤0.01%	932
2022 Q4	$10K	Sell	28 -6	-18%	-$1.69K	﹤0.01%	969
2022 Q3	$8K	Buy	34 +2	+6%	+$536	﹤0.01%	934
2022 Q2	$7K	Buy	+32	New	+$13.8K	﹤0.01%	1323

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Penserra Capital Management's OM Position: Q1 2024 in Review

Penserra Capital Management sold out of Outset Medical (OM) in Q1 2024, closing a stake of 528 shares — an estimated $42K sold.

Penserra Capital Management first reported a position in OM in Q2 2022 and held it in 7 quarters. The position peaked at $92K in Q2 2023. 114 funds tracked by Wall St. Rank hold OM as of Q1 2024.

Penserra Capital Management reported no remaining Outset Medical position as of Q1 2024 after selling out during the quarter.
Penserra Capital Management sold 528 Outset Medical shares in Q1 2024, an estimated $42K.
Penserra Capital Management first reported a position in Outset Medical in Q2 2022 and held it in 7 quarters.
Penserra Capital Management's Outset Medical position peaked at $92K in Q2 2023.
114 funds tracked by Wall St. Rank held Outset Medical as of Q1 2024.

Based on Penserra Capital Management's 13F filing for Q1 2024, filed 15 May 2024.